Ifinatamab

Product Specifications

CAS Number

2484870-90-6

Target

Immunology/Inflammation related|||B7|||Integrin

Related Pathways

Immunology/Inflammation|||Cytoskeletal Signaling

Purity

0.991

Bioactivity

Ifinatamab is a humanised monoclonal immunoglobulin that targets and inhibits the B7-H3 protein. Ifinatamab can be used to synthesise the ADC drug Ifinatamab deruxtecan for the treatment of small cell lung cancer (SCLC) .

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

SR323043 1 Kit

TIMM17B Human siRNA Oligo Duplex (Locus ID 10245)

Ask

View Details

MC205804 10 µg

Arhgap24 (NM_146161) Mouse Untagged Clone

Ask

View Details

RC213860L3 10 µg

ARHGAP4 (NM_001666) Human Tagged Lenti ORF Clone

Ask

View Details

47164141 1x 10^6 Cells / 1.0 mL

TMSB4X CRISPR Knock Out 293T Cell Line (Human)

Ask

View Details

457104-01 50 mg

N- (3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl) glycyl-L-prolinamide

Ask

View Details

457104-02 100 mg

N- (3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl) glycyl-L-prolinamide

Ask

View Details